This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Keith Bowman
Vice President of Process Development at Wave Life Sciences
Speaker

Profile

Keith Bowman is the Vice President of Process Development at Wave Life Sciences. Keith began his career in Oligonucleotides at Ribozyme Pharmaceuticals in 1999 doing downstream process and analytical development. Keith has since held positions of increasing responsibility with SIrna Therapeutics, and Novartis before joining Wave in 2015. Keith currently leads a team of scientists’ who are responsible for process optimization, scale up, process characterization for Wave’s clinical pipeline

Agenda Sessions

  • Confirmation of the Identity of Stereopure Oligonucleotides

    , 09:05
    View Session

At this event

Prev
Next
Dr. Christopher Brown, PhD
Vice President of Discovery
Metagenomi

See Keith at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now